Tongling Jieya Biologic Technology Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 55.38% vs -4.55% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 3.00% vs -28.06% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "192.20",
          "val2": "123.70",
          "chgp": "55.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.80",
          "val2": "16.90",
          "chgp": "-30.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "0.10",
          "chgp": "1,300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "1.00",
          "val2": "1.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "10.30",
          "val2": "10.00",
          "chgp": "3.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "61.20%",
          "val2": "36.70%",
          "chgp": "2.45%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 41.16% vs -11.68% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 303.13% vs -83.23% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "770.60",
          "val2": "545.90",
          "chgp": "41.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "129.80",
          "val2": "62.70",
          "chgp": "107.02%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.80",
          "val2": "0.90",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.00",
          "val2": "-12.40",
          "chgp": "67.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "77.40",
          "val2": "19.20",
          "chgp": "303.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "97.60%",
          "val2": "27.60%",
          "chgp": "7.00%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

192.20

123.70

55.38%

Operating Profit (PBDIT) excl Other Income

11.80

16.90

-30.18%

Interest

1.40

0.10

1,300.00%

Exceptional Items

1.00

1.00

Consolidate Net Profit

10.30

10.00

3.00%

Operating Profit Margin (Excl OI)

61.20%

36.70%

2.45%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 55.38% vs -4.55% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 3.00% vs -28.06% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

770.60

545.90

41.16%

Operating Profit (PBDIT) excl Other Income

129.80

62.70

107.02%

Interest

1.80

0.90

100.00%

Exceptional Items

-4.00

-12.40

67.74%

Consolidate Net Profit

77.40

19.20

303.13%

Operating Profit Margin (Excl OI)

97.60%

27.60%

7.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 41.16% vs -11.68% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 303.13% vs -83.23% in Dec 2024

All Annual Results